Chuanlong Guo Selected Research

Chuanlong Guo Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 07/2013
5	Lung Neoplasms (Lung Cancer) 01/2022 - 07/2013
4	Wounds and Injuries (Trauma) 03/2022 - 02/2021
3	Burns 03/2022 - 08/2021
3	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2020
2	Inflammation (Inflammations) 03/2022 - 12/2021
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022 - 01/2022
2	Corneal Injuries 12/2021 - 08/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 11/2019
2	Dyslipidemias (Dyslipidemia) 01/2019 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2018
1	Cicatrix (Scar) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Ischemia 01/2022
1	Reperfusion Injury 01/2022
1	Infections 02/2021
1	Carcinogenesis 11/2019
1	Obesity 11/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2019
1	Hyperglycemia 01/2019
1	Insulin Resistance 01/2019
1	Hypoxia (Hypoxemia) 11/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Keratitis 08/2014

Drug/Important Bio-Agent (IBA)

3	HydrogelsIBA 03/2022 - 02/2021
3	Pharmaceutical PreparationsIBA 01/2022 - 11/2018
3	Eukaryotic Initiation Factor-4EIBA 01/2022 - 09/2019
3	Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA 01/2022 - 09/2019
3	MicellesIBA 01/2022 - 12/2021
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2019
3	Biological ProductsIBA 09/2019 - 01/2019
2	Small Interfering RNA (siRNA)IBA 01/2022 - 11/2019
2	SilverIBA 01/2022 - 08/2021
2	polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymerIBA 01/2022 - 12/2021
2	AlkaliesIBA 12/2021 - 08/2021
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 05/2019
2	Poly (ADP-Ribose) Polymerase-1IBA 01/2020 - 01/2019
2	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 11/2019 - 01/2019
2	ThiosemicarbazonesIBA 01/2019 - 01/2017
1	Fibroins (Fibroin)IBA 03/2022
1	rheinIBA 03/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	polyvinyl acetateIBA 01/2022
1	pterostilbeneIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Netrin-1IBA 01/2022
1	CaprolactamIBA 01/2022
1	MelatoninIBA 01/2022
1	PolymersIBA 01/2022
1	PolyvinylsIBA 01/2022
1	QuercetinIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	InflammasomesIBA 01/2022
1	Betulinic AcidIBA 12/2021
1	Bovine Serum AlbuminIBA 08/2021
1	Hyaluronic Acid (Hyaluronan)IBA 08/2021
1	hesperetinIBA 01/2021
1	rebaudioside AIBA 01/2021
1	Peptide Initiation Factors (Initiation Factor)IBA 09/2019
1	Caspase 3 (Caspase-3)IBA 05/2019
1	BromidesIBA 04/2019
1	diphenyl (biphenyl)IBA 04/2019
1	Protein Tyrosine PhosphatasesIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018
1	hydrazinecarbothioamideIBA 01/2017
1	Levofloxacin (Levaquin)FDA Link 08/2014
1	balofloxacin (Q 35)IBA 08/2014
1	Ophthalmic Solutions (Eye Drops)IBA 08/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2013
1	fengycinIBA 07/2013

Therapy/Procedure

2	Contact Lenses 12/2021 - 08/2021
2	Oral Administration 01/2019 - 01/2018
1	Transplantation 01/2022
1	Therapeutics 01/2018